TrialCancer2025

Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial.

Yan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.